Nurse care manager series
This video series is aimed at new and current Nurse Care Managers treating patients with opioid use disorder. They were created by members of the ADAI State Opioid Response Training Team with funding from the WA State Health Care Authority. These videos are adapted from the original Nurse Care Manager Foundational Series, which was developed and presented by Addy Adwell, BSN, RN, AMB-BC, and Wendy Williams-Gilbert, PhD, RN, CARN.
Maureen Oscadal, MPH, BSN, RN, CARN, AMB-BC
July 2024
Learn essential information about opioids, opioid dependence, and opioid use disorder.
Overview of Medications for Opioid Use Disorder (MOUD)
Maureen Oscadal, MPH, BSN, RN, CARN, AMB-BC
July 2024
Overview of the three FDA-approved medications for opioid use disorder: methadone, naltrexone, and buprenorphine. Includes evidence supporting the medications’ effectiveness and the role of shared decision-making for choosing a medication.
Maureen Oscadal, MPH, BSN, RN, CARN, AMB-BC
July 2024
Describes the use of buprenorphine for opioid use disorder, including an overview of sublingual and injectable formulations and approaches to starting the medication.
Opioid Use Disorder Care Management & Team-Based Care
Maureen Oscadal, MPH, BSN, RN, CARN, AMB-BC
July 2024
Highlights the role of Nurse Care Managers in supporting patients engaged in MOUD treatment. Learn about team-based care approaches to expand access to MOUD.
Addressing Ongoing Substance Use and Return to Use
Maureen Oscadal, MPH, BSN, RN, CARN, AMB-BC
July 2024
Guidance for Nurse Care Managers to support patients who continue or return to using drugs while on medications for opioid use disorder.
Patient Engagement & Retention in Care
Maureen Oscadal, MPH, BSN, RN, CARN, AMB-BC
July 2024
Learn how Nurse Care Managers can enhance patient engagement in medications for opioid use disorder. This includes how to foster a supportive and collaborative care environment, buprenorphine dose considerations, and practical tips for patient engagement and retention in care.